Cargando…

Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer

SIMPLE SUMMARY: Both short- and long-course neoadjuvant radiotherapy (NA-RT) followed by surgery have been adopted as standard treatments for locally advanced rectal cancer (LARC). We hypothesized that a modified short-course radiotherapy (mSC-RT) using an accelerated hyperfractionated regimen, with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doi, Hiroshi, Yokoyama, Hiroyuki, Beppu, Naohito, Fujiwara, Masayuki, Harui, Shogo, Kakuno, Ayako, Yanagi, Hidenori, Hishikawa, Yoshio, Yamanaka, Naoki, Kamikonya, Norihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394890/ https://www.ncbi.nlm.nih.gov/pubmed/34439265 http://dx.doi.org/10.3390/cancers13164112

Ejemplares similares

Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer
por: Doi, Hiroshi, et al.
Publicado: (2013)

Corrigendum to ‘Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer’(†)
por: Doi, Hiroshi, et al.
Publicado: (2014)

A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)

Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies
por: Beppu, Naohito, et al.
Publicado: (2023)

Erratum for Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies
por: Beppu, Naohito, et al.
Publicado: (2023)

Clinical Implications of a Novel, Iron-containing Fiducial Marker in Radiotherapy for Liver Tumors: An Initial Experience
por: Doi, Hiroshi, et al.
Publicado: (2017)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
por: Wang, Jian, et al.
Publicado: (2021)

Dosimetric and delivery characterizations of full-arc and half-arc volumetric-modulated arc therapy for maxillary cancer
por: Miura, Hideharu, et al.
Publicado: (2012)

Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma
por: Doi, Hiroshi, et al.
Publicado: (2018)

Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma
por: FUJIWARA, YOSHINORI, et al.
Publicado: (2013)

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients
por: FUJIWARA, YOSHINORI, et al.
Publicado: (2012)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
por: Chin, Re-I, et al.
Publicado: (2022)

Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer
por: Kimura, Kei, et al.
Publicado: (2020)

Three-dimensional radiochromic film dosimetry for volumetric modulated arc therapy using a spiral water phantom
por: Tanooka, Masao, et al.
Publicado: (2013)

Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy
por: DOI, HIROSHI, et al.
Publicado: (2014)

The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases
por: Fujiwara, Masayuki, et al.
Publicado: (2015)

The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy
por: Yoshikawa, Reigetsu, et al.
Publicado: (2012)

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma
por: Jia, Angela Y., et al.
Publicado: (2019)

Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
por: Kohl, Valerie K. B., et al.
Publicado: (2022)

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy
por: Koo, Kendrick, et al.
Publicado: (2021)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Sapienza, Lucas G, et al.
Publicado: (2022)

Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial
por: Kim, Min Jung, et al.
Publicado: (2023)

Low-Dose Aspirin Therapy Does not Increase the Severity of Acute Radiation Proctitis
por: Doi, Hiroshi, et al.
Publicado: (2012)

Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial
por: Aghili, Mahdi, et al.
Publicado: (2020)

Short-course or long-course radiation therapy as a part of a neoadjuvant regimen for stage II & III rectal adenocarcinoma?
por: Zhao, Nan, et al.
Publicado: (2019)

Short-Course Radiotherapy in Locally Advanced Rectal Cancer
por: Cambray, Maria, et al.
Publicado: (2020)

Radiotherapy for rectal cancer: Short course versus long course – When and how
por: Sebag-Montefiore, David
Publicado: (2013)

A Prospective Observational Study Comparing Long-Course Conventional Neoadjuvant Chemoradiotherapy with Short-Course Radiotherapy Followed by Consolidation Chemotherapy with Delayed Surgery in Locally Advanced Rectal Cancer
por: Thakur, Niketa, et al.
Publicado: (2020)

Rectal prolapse following short-course radiotherapy for rectal cancer: report of a case
por: Nocera, Fabio, et al.
Publicado: (2020)

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients
por: Napolitano, Maria, et al.
Publicado: (2015)

Effects of neoadjuvant chemotherapy with or without intensity‐modulated radiotherapy for patients with rectal cancer
por: He, Fang, et al.
Publicado: (2020)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
por: Zhang, Qibo, et al.
Publicado: (2021)

Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer
por: Tokuhara, Katsuji, et al.
Publicado: (2022)

Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta-Analysis
por: Yang, Jianguo, et al.
Publicado: (2022)

Organ preservation following short-course radiotherapy for rectal cancer
por: Nilsson, Per J, et al.
Publicado: (2021)

Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study
por: Räsänen, Minna, et al.
Publicado: (2019)

Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
por: Liao, Chun-Kai, et al.
Publicado: (2022)

Malnutrition in rectal cancer patients receiving preoperative chemoradiotherapy is common and associated with treatment tolerability and anastomotic leakage
por: Yamano, Tomoki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3jifg4dq7b7l0l0o7rj56u1lol